Table 3.
Group | Number | Total positive rate (%) | CA199 | NSE | CEA | CA242 | Ferritin | β‐HCG | AFP | f‐PSA | PSA | CA125 | HGH | CA153 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adenocarcinoma | 123 | 69.92 | 44.12 | 8.82 | 61.76a | 35.29a | 32.35 | 5.88 | 2.82 | 2.94 | 2.94 | 73.53a | 0 | 17.65a |
Squamous cell carcinoma | 30 | 60.00 | 22.22 | 0 | 40.56b | 21.11b | 26.67 | 0 | 0 | 0 | 0 | 36.67b | 0 | 10.23b |
Small‐cell carcinoma | 54 | 70.37 | 40.00 | 8.33 | 46.67b | 25.00b | 23.16 | 4.32 | 0 | 4.33 | 0 | 56.62c | 0 | 8.33b |
In the same column, different number (eg, a and b, b and c, a and c) showed there was significant difference between the adenocarcinoma, squamous cell carcinoma and small cell carcinoma group (P < .05). In the same column, the same number (eg, a and a, b and b, c and c) showed there was no significant difference between the adenocarcinoma, squamous cell carcinoma and small cell carcinoma group (P > .05).